Page 2 - ப்ளூம்பெர்க் சனோஃபி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ளூம்பெர்க் சனோஃபி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ளூம்பெர்க் சனோஃபி Today - Breaking & Trending Today

Sanofi to Make Millions of BioNTech-Pfizer's Covid Vaccine Doses


Sanofi to Make Millions of BioNTech-Pfizer Vaccine Doses
Bloomberg
1/27/2021
© Bloomberg
BioNTech will give Sanofi access to its Frankfurt production facility.
(Bloomberg) Sanofi agreed to produce millions of doses of BioNTech SE and Pfizer Inc.’s coronavirus vaccine in an unusual collaboration to speed vaccination efforts.
The French drugmaker will give BioNTech access to a production facility in Frankfurt, which will start to deliver doses this summer, Sanofi said in a statement Wednesday. The deal will produce more than 125 million doses of the messenger RNA vaccine for the European Union.
Sanofi’s own effort to develop a Covid vaccine has stumbled, meaning it won’t be ready by summer as initially expected. The deal with BioNTech allows Europe to make up for some of the loss. The pact also raised hopes that more pharma giants would throw their manufacturing and distribution weight behind the few coronavirus shots that have proved effecti ....

France General , Bloomberg Sanofi , Glaxosmithkline Plc , Pfizer Inc , European Union , பிரான்ஸ் ஜநரல் , ப்ளூம்பெர்க் சனோஃபி , கிளாக்சோஸ்மித்க்லைன் ப்ல் , ஃபைசர் இன்க் , ஐரோப்பிய தொழிற்சங்கம் ,

Sanofi to Make Millions of BioNTech-Pfizer Vaccine Doses


Sanofi to Make Millions of BioNTech-Pfizer Vaccine Doses
Bloomberg
1/27/2021
© Bloomberg
BioNTech will give Sanofi access to its Frankfurt production facility.
(Bloomberg) Sanofi agreed to produce millions of doses of BioNTech SE and Pfizer Inc.’s coronavirus vaccine in an unusual collaboration to speed vaccination efforts.
The French drugmaker will give BioNTech access to a production facility in Frankfurt, which will start to deliver doses this summer, Sanofi said in a statement Wednesday. The deal will produce more than 125 million doses of the messenger RNA vaccine for the European Union.
Sanofi’s own effort to develop a Covid vaccine has stumbled, meaning it won’t be ready by summer as initially expected. The deal with BioNTech allows Europe to make up for some of the loss. The pact also raised hopes that more pharma giants would throw their manufacturing and distribution weight behind the few coronavirus shots that have proved effecti ....

France General , Bloomberg Biontech , Bloomberg Sanofi , Olivier Bogillot , Glaxosmithkline Plc , Pfizer Inc , European Union , Lonza Group , Moderna Inc , பிரான்ஸ் ஜநரல் , ப்ளூம்பெர்க் சனோஃபி , கிளாக்சோஸ்மித்க்லைன் ப்ல் , ஃபைசர் இன்க் , ஐரோப்பிய தொழிற்சங்கம் , மாடர்னா இன்க் ,

Sanofi to Make BioNTech Vaccine; Astra's Troubles: Virus Update


Cuomo Says Surge Over; EU, Astra Feud Escalates: Virus Update
Bloomberg
1/27/2021
Bloomberg News
© Photographer: Jeff Pachoud/AFP via Getty Images
A nurse washes a Covid-19 patient at a hospital in Pierre-Benite, France, on Jan. 25.
(Bloomberg) Governor Andrew Cuomo lifted restrictions in most hot spots across New York state, declaring an end to the post-holiday surge in cases and hospitalizations. New York City said it will receive 17,000 additional vaccine shots next week, after the Biden administration boosted deliveries.
The European Union failed to resolve its dispute with AstraZeneca Plc over vaccine supplies, raising the risk of additional delays to the bloc’s sluggish inoculation campaign and putting the drugmaker on a collision course with 27 governments. The quarrel could add another thorn to the tumultuous post-Brexit ties between Britain and the EU. ....

North West , South Africa , New York , United States , City Of , United Kingdom , Noord Holland , Pierre Benite , New Zealand , New Jersey , Krung Thep Mahanakhon , South Korea , South Korean , Bruno Le Maire , Yoshihide Suga , Emer Cooke , Phil Murphy , Jeff Pachoud , Francisco Sagasti , Zeng Yixin , Quicktakewhy Covid , Sergei Sobyanin , Bloomberg Sanofi , Johns Hopkins University , Glaxosmithkline Plc , National Health Commission ,

Sanofi to Buy Antibody Maker Kymab in $1.45 Billion Deal


Sanofi to Buy Antibody Maker Kymab in $1.45 Billion Deal
Bloomberg
1/11/2021
Tim Loh
© Photographer: JOEL SAGET/AFP
Sanofi has been hunting for acquisitions to bolster its pipeline of new medicines.
(Bloomberg) Sanofi agreed to buy the U.K. monoclonal antibody developer Kymab in a deal worth as much as $1.45 billion to gain experimental medicines for inflammation diseases as well as cancer.
The French drugmaker will obtain global rights to KY1005, a human monoclonal antibody with a new mechanism of action and the potential to treat a variety of disorders, the Paris-based company said in a statement.
Sanofi has been hunting for acquisitions to bolster its pipeline, and the deal continues the company’s pivot toward treatments targeting the immune system. The Kymab agreement comes after Sanofi agreed to spend $3.4 billion for U.S. biotech company Principia Biopharma Inc., which developed a pipeline of drugs known as BTK inhibi ....

United Kingdom , France General , Bloomberg Sanofi , Principia Biopharma Inc , England Based Kymab , ஒன்றுபட்டது கிஂக்டம் , பிரான்ஸ் ஜநரல் , ப்ளூம்பெர்க் சனோஃபி ,